SCHEMBL699496

SCHEMBL699496

CCCC[PH+](CCCC)CCCC.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
LTA4H P09960 2/20 0.34
PCSK9 Q8NBP7 1/20 0.34
ALDH1A1 P00352 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
PTGS2 P35354 1/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTPN1 P18031 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
HSD11B1 P28845 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL4386676 0.89 MMP2 (0.37) TSHRMAPTLMNAPTPN1SMN1; SMN2
SCHEMBL25312239 0.87 ALDH1A1 (0.34) ALDH1A1NPSR1LMNAHSD17B10SMN1; SMN2
Octane SCHEMBL18395350 0.82 DNM1 (0.44) TSHRLTA4HSMN1; SMN2SIGMAR1CES2
SCHEMBL703014 0.81 PTGS2 (0.33) TSHRLTA4HPCSK9ALDH1A1NPSR1
SCHEMBL10434550 0.80 LTA4H (0.39) TSHRLTA4HPCSK9ALDH1A1MAPT
Octane SCHEMBL23754774 0.80 DNM1 (0.42) LTA4HALDH1A1SMN1; SMN2SIGMAR1CES2
SCHEMBL10357730 0.79 TP53 (0.41) TSHRLTA4HPCSK9ALDH1A1NPSR1
SCHEMBL335798 0.78 TP53 (0.36) ALDH1A1NPSR1MAPTLMNAHSD17B10
Butylamine SCHEMBL627676 0.77 DNM1 (0.39) TSHRLTA4HPCSK9ALDH1A1NPSR1
Tetrabuthylammonium SCHEMBL14916 0.75 SLC22A1 (0.50) TSHRALDH1A1LMNAHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119403812-A Ligand compound, organic chromium compound, and catalyst composition containing same 株式会社LG化学 2025-02-07 CN disclosed
CN-119365472-A Ligand compound, organic chromium compound, and catalyst composition comprising same 株式会社LG化学 2025-01-24 CN disclosed
CN-119173521-A Ligand compound, organic chromium compound, and catalyst composition comprising same 株式会社LG化学 2024-12-20 CN disclosed
EP-1688424-B1 PHOSPHONIUM BORATE COMPOUND AND METHOD OF USING THE SAME HOKKO CHEM IND CO (JP) 2016-01-13 EP disclosed
US-8604249-B2 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2013-12-10 US disclosed
US-8124809-B2 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2012-02-28 US disclosed
US-20110237799-A1 Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2011-09-29 US disclosed
US-20110166389-A1 Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2011-07-07 US disclosed
US-7728176-B2 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2010-06-01 US disclosed
US-20090305877-A1 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2009-12-10 US disclosed
US-20070098616-A1 Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2007-05-03 US disclosed
EP-1688424-A1 PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) 2006-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166389-A1 Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same CA4, EPB41, MAPK4 TSHR 2082/4885LTA4H 2656/4885PCSK9 3352/4885
US-20110237799-A1 Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same EPB41, CA4, RBBP4 TSHR 1831/4885LTA4H 2917/4885PCSK9 3456/4885
US-20090305877-A1 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same PHOSPHO1, BRI3BP, CA4 TSHR 1382/4885LTA4H 2104/4885PCSK9 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.